Mini-Tumors grown in lab could predict breast cancer treatment response
NCT ID NCT05317221
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to create a 'living biobank' of breast cancer organoids—tiny 3D tumor models grown from patient tissue. Researchers will test whether these organoids can predict how a patient's cancer will behave and respond to treatments. The goal is to develop better tools for personalized breast cancer care. The study will involve 60 women with breast cancer who are scheduled for surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Maastricht University Medical Center
RECRUITINGMaastricht, 6202 AZ, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?